학술논문

Exposure-Response Relationship of the SMART-Ig Anti-hC5 Antibody Crovalimab (SKY59): Results from the Umbrella Phase 1/2 Composer Trial in Healthy Volunteers and PNH Patients
Document Type
Abstract
Source
In Blood 13 November 2019 134 Supplement 1:3745-3745
Subject
Language
ISSN
0006-4971